Abstract:Background: Depression and anxiety have been correlated with elevated risks for quality-of-life (QOL), adverse outcomes, and medical expenditure in patients with acute coronary syndrome (ACS). However, the relevant data are lacking for Chinese ACS populations, especially regarding different effects of major depression, anxiety, and comorbidity. The objective of this study was to evaluate the dynamic changes of depression and/or anxiety over 12 months and examine the effects of depression, anxiety, and comorbidity on QOL, adverse outcomes, and medical expenditure in Chinese patients with ACS. Methods: For this prospective longitudinal study, a total of 647 patients with ACS were recruited from North China between January 2013 and June 2015. Among them, 531 patients (82.1%) completed 12-month follow-ups. Logistic regression model was utilized for analyzing the association of baseline major depression, anxiety, and comorbidity with 12-month all-cause mortality, cardiovascular events, QOL, and health expenditure. Results: During a follow-up period of 12 months, 7.3% experienced non-fatal myocardial infarction (MI) and 35.8% cardiac rehospitalization. Baseline comorbidity, rather than major depression/anxiety, strongly predicted poor 12-month QOL as measured by short-form health survey-12 (odds ratio [OR]: 1.77, 95% confidence interval [CI]: 1.22-2.52, P = 0.003). Regarding 12-month non-fatal MI and cardiac re-hospitalization, baseline anxiety (OR: 2.83, 95% CI: 1.33-5.89, P < 0.01; OR: 4.47, 95% CI: 1.50-13.00, P < 0.01), major depression (OR: 2.58, 95% CI: 1.02-6.15, P < 0.05; OR: 5.22, 95% CI: 1.42-17.57, P < 0.03), and comorbidity (OR: 6.33, 95% CI: 2.96-13.79, P < 0.0001, OR: 14.08, 95% CI: 4.99-41.66, P < 0.0001) were all independent predictors, and comorbidity had the highest predictive value. Number of re-hospitalization stay, admission frequency within 12 months and medical expenditure within 2 months were the highest in patients with ACS with comorbidity. Conclusions: Major depression and anxiety may predict 12-month non-fatal MI and cardiac re-hospitalization. However, comorbidity has the highest predictive value with greater medical expenditure and worse QOL in Chinese patients with ACS. And depression with comorbid anxiety may be a new target of mood status in patients with ACS.

Comorbid Generalized Anxiety Disorder and Its Association with Quality of Life in Patients with Major Depressive Disorder.

Multi-center study of the clinical features in depression comorbidity with anxiety disorders

Risk Factors for Anxiety in Major Depressive Disorder Patients

Prescribing Patterns of Psychotropic Medications and Clinical Features in Patients with Major Depressive Disorder with and Without Comorbid Dysthymia in China

Potential risk factors of comorbidity of major depressive disorder and generalized anxiety disorder-results of a multicenter cross-sectional study

Clinical study of major depression comorbid with anxiety

The Clinical Correlates of Comorbid Anxiety Symptoms and Syndromal Anxiety in Patients with Major Depressive Disorder.

Disorder-specific impaired neurocognitive function in major depression and generalized anxiety disorder

Characteristics and related factors of comorbidity among patients with depression disorder

Major depressive disorder comorbid with general anxiety disorder: Associations among neuroticism, adult stress, and the inflammatory index

Comparing the Effects of Depression, Anxiety, and Comorbidity on Quality-of-life, Adverse Outcomes, and Medical Expenditure in Chinese Patients with Acute Coronary Syndrome.

Influence of Comorbid Anxiety Symptoms on Cognitive Deficits in Patients with Major Depressive Disorder.

Comorbidity of Depressive and Anxiety Disorders:Challenges in Diagnosis and Assessment

Gender-specific Prevalence and Associated Factors of Major Depressive Disorder and Generalized Anxiety Disorder in a Chinese Rural Population: the Henan Rural Cohort Study

The Prevalence and Clinical Correlates of Anxiety in Chinese Patients with First-Episode and Drug-Naïve Major Depressive Disorder at Different Ages of Onset

Comorbidity of Anxiety and Depression in Geriatric Patients

Generalized anxiety disorder in China: prevalence, sociodemographic correlates, comorbidity, and suicide attempts.

Co-Morbidity of DSM-IV Personality Disorder in Major Depressive Disorder among Psychiatric Outpatients in China: A Further Analysis of an Epidemiologic Survey in a Clinical Population

Patterns of co-morbidity with anxiety disorders in Chinese women with recurrent major depression.

Dyspepsia is Strongly Associated with Major Depression and Generalised Anxiety Disorder ‐ a Community Study

Prevalence and clinical correlates of benzodiazepine use in the patients with major depressive disorder